GDF15 and depressive symptom measurement: Serum sCD40L levels are also significantly elevated in individuals with depression, further increasing their risk of cardiovascular disease (44, 45).Therefore, GDF15 and sCD40L may serve as surrogate endpoints for predicting adverse cardiovascular events and may also reflect the severity of depressive symptoms.